Iyo yakakura-spectrum yechishanu-chizvarwa cephalosporin antibiotic, Zevtera (Ceftobiprole medocaril sodium Inj.) yakabvumidzwa ne FDA1 nokuti mabatiro yezvirwere zvitatu zvinoti.
- Staphylococcus aureus bloodstream infections (bacteremia) (SAB), kusanganisira avo vane kodzero-sided infective endocarditis;
- acute bhakitiriya ganda uye ganda chimiro zvirwere (ABSSSI); uye
- nharaunda-inotorwa bacterial pneumonia (CABP).
Izvi zvinotevera zvinogutsa chikamu 3 chekiriniki miedzo yemhedzisiro.
Ceftobiprole medocaril inotenderwa munyika zhinji dzeEurope, pamwe neCanada pakurapa mabayo anowanikwa muchipatara (kusingasanganisire mabayo anowanikwa nemhepo) uye mabayo anowanikwa munharaunda muvakuru.2.
MuUK, Ceftobiprole medocaril parizvino iri muchikamu chechitatu chekuyedzwa kwekiriniki3 zvisinei, inogamuchirwa kushandiswa kwakaganhurirwa mukati meNHS Scotland4.
MuEU, inoonekwa muUnion Register yezvigadzirwa zvemishonga zvakarambwa zvekushandisa kwevanhu5.
Ceftobiprole medocaril, chizvarwa chechishanu yakazara-chakarondedzera cephalosporin inoshanda pakurwisa mabhakitiriya eGram-positive akadai semethicillin-resistant Staphylococcus aureus uye penicillin-resistant Streptococcus pneumoniae, uye kurwisa mabhakitiriya eGram-negative akadai sePseudomonas aeruginosa. Yakawanikwa ichibatsira mukurapa pneumonia inowanikwa munharaunda uye nosocomial pneumonia, kunze kwepneumonia inosanganisirwa nemhepo.6,7.
***
References:
- FDA Nhau dzinobudiswa. FDA Inobvumira Nyowani Antibiotic Yemashandisirwo Matatu Akasiyana. Yakatumirwa 03 Kubvumbi 2024. Inowanikwa pa https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibiotic-three-different-uses/
- Jame W., Basgut B., uye Abdi A., 2024. Ceftobiprole mono-therapy versus musanganiswa kana isiri-musanganiswa regimen yechiyero mishonga kuitira kurapwa kwezvirwere zvakaoma: Kuongorora kwakarongeka uye meta-analysis. Diagnostic Microbiology uye Chirwere Chetachiona. Inowanikwa online 16 Kurume 2024, 116263. DOI: https://doi.org/10.1016/j.diagmicrobio.2024.116263
- NIHR. Health Technology Briefing Mbudzi 2022. Ceftobiprole medocaril yekurapa mabayo anotorwa muchipatara kana mabayo anowanikwa munharaunda anoda kuti varapwe muchipatara muvana. Inowanikwa pa https://www.io.nihr.ac.uk/wp-content/uploads/2023/04/28893-Ceftobiprole-medocaril-for-pneumonia-V1.0-NOV2022-NONCONF.pdf
- Scottish Medicine Consortium. Ceftobiprole medocaril (Zevtera). Inowanikwa pa https://www.scottishmedicines.org.uk/medicines-advice/ceftobiprole-medocaril-zevtera-resubmission-94314/
- European Commission. Union Register yezvakarambwa mishonga yekushandiswa kwevanhu. Yakapedzisira kugadziridzwa musi wa21 Kukadzi 2024. Inowanikwa pa https://ec.europa.eu/health/documents/community-register/html/ho10801.htm
- Lupia T., and said 2022. Maonero eCeftobiprole: Zvazvino uye Zvinogona Kuratidza Ramangwana. Antibiotics Vhoriyamu 10 Nyaya 2. DOI: https://doi.org/10.3390/antibiotics10020170
- Méndez1 R., Latorre A., uye González-Jiménez P., 2022. Ceftobiprole medocaril. Rev Esp Quimioter. 2022; 35(Zviwedzerwa 1): 25–27. Rakadhindwa pamhepo 2022 Kubvumbi 22. DOI: https://doi.org/10.37201/req/s01.05.2022
***